Greater Cannabis Company (GCAN) Revenue (2017 - 2021)

Greater Cannabis Company's Revenue history runs 5 years deep, the most recent figure standing at $12630.0 for Q2 2021.

• On a quarterly basis, Revenue fell 73.71% year-over-year to $12630.0 in Q2 2021; TTM through Dec 2021 was $12630.0, a 75.96% decrease from a year earlier, with the FY2021 full-year figure at $12630.0, down 73.71% from the prior year.
• Revenue eased to $12630.0 in Q2 2021 per GCAN's latest filing, from $48044.0 in the prior quarter.
• Across five years, Revenue topped out at $86898.0 in Q4 2018 and bottomed at $73.0 in Q2 2017.
• The 5-year median for Revenue is $12630.0 (2021), against an average of $27808.4.
• Across the five-year window, Revenue soared 30671.23% in 2018 and slumped 94.82% in 2019, its largest moves.
• Year by year, Revenue stood at $136.0 in 2017, then soared by 63795.59% to $86898.0 in 2018, then slumped by 94.82% to $4500.0 in 2019, then soared by 967.64% to $48044.0 in 2020, then sank by 73.71% to $12630.0 in 2021.
• Per Business Quant, the three latest GCAN Revenue figures stand at $12630.0 (Q2 2021), $48044.0 (Q2 2020), and $4500.0 (Q4 2019).